Literature DB >> 10606746

Structure of acetylcholinesterase complexed with (-)-galanthamine at 2.3 A resolution.

H M Greenblatt1, G Kryger, T Lewis, I Silman, J L Sussman.   

Abstract

(-)-Galanthamine (GAL), an alkaloid from the flower, the common snowdrop (Galanthus nivalis), shows anticholinesterase activity. This property has made GAL the target of research as to its effectiveness in the treatment of Alzheimer's disease. We have solved the X-ray crystal structure of GAL bound in the active site of Torpedo californica acetylcholinesterase (TcAChE) to 2.3 A resolution. The inhibitor binds at the base of the active site gorge of TcAChE, interacting with both the choline-binding site (Trp-84) and the acyl-binding pocket (Phe-288, Phe-290). The tertiary amine group of GAL does not interact closely with Trp-84; rather, the double bond of its cyclohexene ring stacks against the indole ring. The tertiary amine appears to make a non-conventional hydrogen bond, via its N-methyl group, to Asp-72, near the top of the gorge. The hydroxyl group of the inhibitor makes a strong hydrogen bond (2.7 A) with Glu-199. The relatively tight binding of GAL to TcAChE appears to arise from a number of moderate to weak interactions with the protein, coupled to a low entropy cost for binding due to the rigid nature of the inhibitor.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10606746     DOI: 10.1016/s0014-5793(99)01637-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  56 in total

1.  Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site.

Authors:  Yves Bourne; Palmer Taylor; Zoran Radić; Pascale Marchot
Journal:  EMBO J       Date:  2003-01-02       Impact factor: 11.598

2.  Electronic structure and PCA analysis of covalent and non-covalent acetylcholinesterase inhibitors.

Authors:  Erica Cristina Moreno Nascimento; João B L Martins
Journal:  J Mol Model       Date:  2010-09-14       Impact factor: 1.810

3.  The Recognition of Identical Ligands by Unrelated Proteins.

Authors:  Sarah Barelier; Teague Sterling; Matthew J O'Meara; Brian K Shoichet
Journal:  ACS Chem Biol       Date:  2015-10-12       Impact factor: 5.100

4.  Acetylcholine nicotinic receptors: finding the putative binding site of allosteric modulators using the "blind docking" approach.

Authors:  Bogdan Iorga; Denyse Herlem; Elvina Barré; Catherine Guillou
Journal:  J Mol Model       Date:  2005-12-22       Impact factor: 1.810

5.  Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics.

Authors:  Yechun Xu; Jacques-Philippe Colletier; Martin Weik; Hualiang Jiang; John Moult; Israel Silman; Joel L Sussman
Journal:  Biophys J       Date:  2008-05-23       Impact factor: 4.033

6.  Molecular docking study on the "back door" hypothesis for product clearance in acetylcholinesterase.

Authors:  Laleh Alisaraie; Gregor Fels
Journal:  J Mol Model       Date:  2005-12-09       Impact factor: 1.810

7.  Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.

Authors:  William Horton; Abha Sood; Swarada Peerannawar; Nandor Kugyela; Aditya Kulkarni; Rekha Tulsan; Chris D Tran; Jessica Soule; Harry LeVine; Béla Török; Marianna Török
Journal:  Bioorg Med Chem Lett       Date:  2016-11-24       Impact factor: 2.823

Review 8.  Cholinergic modulation by opioid receptor ligands: potential application to Alzheimer's disease.

Authors:  William C Motel; Andrew Coop; Christopher W Cunningham
Journal:  Mini Rev Med Chem       Date:  2013-03       Impact factor: 3.862

9.  Molecular docking and receptor-specific 3D-QSAR studies of acetylcholinesterase inhibitors.

Authors:  Pran Kishore Deb; Anuradha Sharma; Poonam Piplani; Raghuram Rao Akkinepally
Journal:  Mol Divers       Date:  2012-09-21       Impact factor: 2.943

Review 10.  Multi-Target Drug Candidates for Multifactorial Alzheimer's Disease: AChE and NMDAR as Molecular Targets.

Authors:  Md Sahab Uddin; Abdullah Al Mamun; Md Tanvir Kabir; Ghulam Md Ashraf; May N Bin-Jumah; Mohamed M Abdel-Daim
Journal:  Mol Neurobiol       Date:  2020-09-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.